Regeneron Pharmaceuticals

IPO

Moving Science to Medicine.

Public · Tarrytown, United States · Founded 1988

Employees
10001+
Founded
1988
Business Model
B2B
Type
Public

About

Regeneron Pharmaceuticals is an American biotechnology company founded in 1988 and headquartered in Tarrytown, New York, that invents, develops, and commercializes medicines for people with serious diseases. The company's therapeutic focus spans eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, hematology, infectious diseases, and rare diseases. Regeneron leverages proprietary technology platforms such as VelociSuite to produce fully human antibodies and bispecific antibodies, with 15 approved medicines developed in-house and nearly 50 candidates in its development pipeline.

Summary

Regeneron Pharmaceuticals is a Biotech company based in Tarrytown, United States, founded in 1988.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOVenture Round
$99.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Regeneron Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/regeneron-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/regeneron-pharmaceuticals" alt="Regeneron Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>